Dapsone Tablet
Product Images NDC 60429-495

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Dapsone (NDC 60429-495). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Golden State Medical Supply, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

60429 495 30ol

This is the description of Dapsone, a drug available in tablet form. Each tablet contains 25 mg of Dapsone and should be protected from light, stored in a tight, light-resistant container, and kept out of reach of children. The package insert provides dosage information. This drug is manufactured by Nostrum Laboratories, Inc. in Kansas City, MO and packaged by GSMS, Incorporated in Camarillo, CA. The NDC code for this drug is 60429-495-30.*

FDA Label Image

60429 496 30ol

GSMS Incorporated, in partnership with Nostrum Laboratories, manufactures and packages Dapsone tablets of USP standard, intended for oral administration. Each tablet contains 100mg of dapsone, which is used to treat leprosy and dermatitis herpetiformis. The package insert contains information on dosage, and the tablets should be stored in a tightly sealed container, protected from light, at room temperature. It is essential to keep the medication away from children. The product is packaged in Camarillo, CA, and manufactured by Nostrum Laboratories Inc., based out of Kansas City.*

FDA Label Image

Figure (Dapsone Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.